Ipx-822 ~repack~ [Trusted 2025]
To validate its efficacy before human trials, researchers utilized advanced PhysioMimix Organ-on-a-Chip technology, which provides a human-relevant model of the liver. This approach allowed the development team to observe how the drug interacts with human cells in a simulated environment, reducing the reliance on traditional animal models that often fail to replicate human metabolic responses. Clinical Progress
IPX-822 is currently being evaluated in ongoing clinical trials for the treatment of autoimmune diseases. A phase 2 trial is investigating the safety and efficacy of IPX-822 in patients with rheumatoid arthritis who have failed or are intolerant to existing therapies. Another phase 2 trial is evaluating IPX-822 in patients with multiple sclerosis. IPX-822
: A device rated IPX8 is designed for continuous immersion in water under conditions specified by the manufacturer, typically deeper than 1 meter (approx. 3.3 feet). To validate its efficacy before human trials, researchers

















